capital raising, page-74

thanks Chinesewhisper, So now, we need to find out how the new Listing for Alchemia Oncology goes. possibly could go very well if handled correctly. there is still plenty of overseas money looking for a good home here in this sector. they should have stunning Phase Two Data for SCLC to support the float.

They must also be confidant that the FONDA data will support the assets left behind. now they will have to issue stock for holders and dilute the Alchemia Oncology for more capital.

So it becomes a sales job. Who is going to handle this. hopefully they will enlist high quality outside talent to make this work.

Whatever way it goes, we are in this for a few months yet. fingers crossed. because it is the outside validation of the Value of HyAct platform that we see if we all get out money back.